The Inspector General for the U.S. Department of Justice is assessing whether the Drug Enforcement Administration’s regulatory activities and enforcement efforts effectively prevent the diversion of controlled substances, particularly opioids, to unauthorized users. The Office of Inspector General's review will examine DEA’s enforcement policies and procedures to regulate registra... Read More